Professional Documents
Culture Documents
A. LESSON REVIEW/PREVIEW
B. MAIN LESSON
Intravenous therapy is treatment that infuses intravenous solutions, medications, blood, or blood
products directly into a vein. Intravenous therapy is an effective and fast-acting way to administer fluid
or medication treatment in an emergency situation, and for patients who are unable to take medications
orally. Approximately 80% of all patients in the hospital setting will receive intravenous therapy.
To replace fluids and electrolytes and maintain fluid and electrolyte balance: The body’s fluid balance is
regulated through hormones and is affected by fluid volumes, distribution of fluids in the body, and the
concentration of solutes in the fluid. If a patient is ill and has fluid loss related to decreased intake,
surgery, vomiting, diarrhea, or diaphoresis, the patient may require IV therapy.
To administer medications, including chemotherapy, anesthetics, and diagnostic reagants: About 40%
of all antibiotics are given intravenously.
To administer blood or blood products: The donated blood from another individual can be used in
surgery, to treat medical conditions such as shock or trauma, or to treat a failure in the production of
red blood cells. The infusion restores circulating volumes, improving the ability to carry oxygen and
replace blood components that are deficient in the body.
To deliver nutrients and nutritional supplements: IV therapy can deliver some or all of the nutritional
requirements for patients unable to obtain adequate amounts orally or by other routes.
INTRAVENOUS SOLUTIONS
The use of IV therapy for a patient with an alteration in fluid and electrolyte balance is common in nursing
practice. Many prepared IV solutions are available for use.
IV solutions fall into several categories: isotonic, hypotonic, and hypertonic. (types of IV solutions are shown
below at the chart)
1. Isotonic fluids have the same osmolality as body fluids and are used to replace extracellular
volume (e.g., prolonged vomiting). They effectively mimic the fluid loss of the body in the absence
of an electrolyte imbalance.
2. Hypotonic solutions are those that have an effective osmolality less than that of body fluids and
are used most often to hydrate cells (e.g., hypertonic dehydration, required water replacement).
3. Hypertonic solutions are those that have an effective osmolality greater than body fluids and
are used most often to increase extracellular fluid volume (e.g., replace electrolytes, treat shock).
A patient’s specific fluid and electrolyte imbalance and serum electrolyte values guide the need for
administration of the appropriate IV fluid.
INTRAVENOUS CATHETERS
To administer IV solutions and medications, a venous access device (VAD) is inserted into a vein
with the final tip residing in a location that is appropriate for the pH and osmolarity of the solution
or medication.
Solutions and medications with a pH of less than 5.0 or greater than 9.0 and an osmolarity
greater than 600 mOsm/L are infused with a central vascular access device (CVAD) with final tip
placement in the superior or inferior vena cava.
Solutions and medications with a pH between 5.0 and 9.0 and an osmolarity less than 600
Solutions or medications with low or high pH and high osmolarity have the potential to cause
infusion-related complications such as phlebitis when administered with a short peripheral or
midline catheter.
Table below outlines the vascular access device (VAD) options for peripheral administration.
Table below indicates the appropriate uses for the more common catheter sizes and colors.
IV fluid therapy is ordered by a physician or nurse practitioner. The order must include the type of
solution or medication, rate of infusion, duration, date, and time. IV therapy may be for short or
long duration, depending on the needs of the patient.
IV therapy is an invasive procedure, and therefore significant complications can occur if the
wrong amount of IV fluids or the incorrect medication is given.
Aseptic technique must be maintained throughout all IV therapy procedures, including initiation of
IV therapy, preparing and maintaining equipment, and discontinuing an IV system. Always
perform hand hygiene before handling all IV equipment. If an administration set or solution
becomes contaminated with a non-sterile surface, it should be replaced with a new one to
prevent introducing bacteria or other contaminants into the system.
Understand the indications and duration for IV therapy for each patient. Practice guidelines
recommend that patients receiving IV therapy for more than six days should be assessed for an
intermediate or long-term device.
If a patient has an order to keep a vein open, or “TKVO,” the usual rate of infusion is 20 to 50 ml
per hour.
Complications may occur with IV therapy, including but not limited to localized infection, catheter-
related bloodstream infection (CR-BSI), fluid overload, and complications related to the type and
Upper extremities (hands and arms) are the preferred sites for insertion by a specially trained
health care provider. If a lower extremity is used, remove the peripheral IV and re-site in the
upper extremities as soon as possible.
PIVs are used for infusions under six days and for solutions that are iso-osmotic or near iso-
osmotic.
They are easy to monitor and can be inserted at the bedside. CDC (2011) recommends that PIVs
be replaced every 72 to 96 hours to prevent infection and phlebitis in adults.
Most agencies require training to initiate IV therapy, but the care and preparation of equipment,
and the maintenance of an IV system can be completed each shift by the trained health care
provider. For more information on how to initiate IV therapy.
PIVs are prone to phlebitis and infection, and should be removed as follows:
Phlebitis Phlebitis is the inflammation of the vein’s inner lining, the tunica intima. Clinical
indications are localized redness, pain, heat, and swelling, which can track up the vein
leading to a palpable venous cord.
Mechanical causes: Inflammation of the vein’s inner lining can be caused by the
cannula rubbing and irritating the vein. It is recommended to use the smallest gauge
possible to deliver the medication or required fluids.
Chemical causes: Inflammation of the vein’s inner lining can be caused by medications
with a high alkaline, acidic, or hypertonic solutions.
Treatment: Immediately remove cannula. May elevate arm or apply a warm compress.
Document findings in chart. Initiate a new peripheral IV if necessary.
Treatment: Stop infusion and remove cannula. Follow agency policy related to
infiltration. Always secure peripheral catheter with tape or IV stabilization device to
avoid accidental dislodgement. Avoid areas of flexion and always assess IV site prior to
giving IV fluids or IV medications.
Treatment: Stop infusion and remove cannula. Follow agency policy for extravasation
for specific medications. For example, toxic medications have a specific treatment plan.
Treatment: Apply gauze to the site until the bleeding stops, then apply a sterile
transparent dressing.
Local Local infection is indicated by purulent drainage from site, usually two to three days
infection at after an IV site is started.
IV site
Treatment: Remove cannula and clean site using sterile technique. Monitor for signs
and symptoms of systemic infection.
Safety considerations:
To avoid air embolisms, ensure drip chamber is one-third to one-half filled, ensure all
IV connections are tight, ensure clamps are used when IV system is not in use, and
remove all air from IV tubing by priming prior to attaching to patient.
Catheter A catheter embolism occurs when a small part of the cannula breaks off and flows
embolism into the vascular system. When removing a peripheral IV cannula, inspect tip to
ensure end is intact.
Catheter- Catheter-related bloodstream infection (CR-BSI) is caused by microorganisms that
related are introduced into the blood through the puncture site, the hub, or contaminated IV
bloodstream tubing or IV solution, leading to bacteremia or sepsis. A CR-BSI is a nosocomial
infection preventable infection and an adverse event.
CR-BSI is confirmed in a patient with a vascular device (or a patient who had such a
device in the last 48 hours before the infection) and no apparent source for the
infection other than the vascular access device with one positive blood culture.
CVCs have become common in health care settings for patients who require IV medication
administration and other IV treatment requirements.
CVCs can remain in place for more than one year. Some CVC devices may be inserted at the
bedside, while other central lines are inserted surgically.
Central lines are inserted by a physician or specially trained health care provider, and the use of
ultrasound guided placement is recommended to reduce time of insertion and complications.
CVC has many advantages over a peripheral IV line, including the ability to deliver fluids or
medications that would be overly irritating to peripheral veins, and the ability to access multiple
lumens to deliver multiple medications at the same time
Central venous catheters can be inserted percutaneously or surgically through the jugular,
subclavian, or femoral veins, or via the chest or upper arm peripheral veins.
Femoral veins are not recommended, as the rate of infection is increased in adults.
CVCs are typically inserted for patients requiring more than six days of intravenous therapy or who:
Have had multiple PIV insertions/attempts (e.g., two attempts by two different IV therapy
practitioners)
Central venous catheter (CVC) with three lumens Peripherally inserted central catheter (PICC) with one lumen
1. The nurse consistently observes that the positioning of a confused patient's arm has a direct effect
on the flow rate of the intravenous (IV) solution. What might the nurse do to ensure infusion of the
patient's IV fluid at a consistent rate?
a. Restart the IV in another location less affected by the patient's positioning.
b. Include this information in the shift report regarding this patient.
c. Assess the flow rate every 1 to 2 hours.
d. Instruct the patient to avoid positioning the arm in ways that alter the flow rate of the solution.
2. Which instruction might the nurse give to nursing assistive personnel (NAP) regarding the care of a
patient with a venous access device?
a. "Assess the IV site frequently for signs of inflammation."
b. "Be sure not to obscure the insertion site with the dressing."
c. "Let me know if you notice that the dressing has become damp."
d. "Make sure the patient knows to notify me if the IV site becomes painful, swollen, or red."
3. What might the nurse do to minimize the risk for injury in a patient receiving IV therapy?
a. Regulate the flow rate of the infusion.
b. Assess the patient frequently for pain at the IV site.
c. Monitor the IV site frequently for signs of infiltration and phlebitis.
d. Educate the patient regarding symptoms of infiltration and phlebitis.
4. The nurse observes erythema at the insertion site of a patient's IV infusion device. When asked,
the patient denies pain at the site. Using the phlebitis scale, what score does the nurse give the
injury?
a. 1
b. 2
c. 3
d. 4
5. A patient's IV site has developed phlebitis scored as a 4 on the phlebitis scale. What would the
nurse do to help treat the site?
a. Apply a cool compress.
b. Apply a warm compress.
c. Apply a pressure dressing.
d. Apply an elastic compression wrap.
6. How would the nurse assess a patient's central venous access device (CVAD) for damage or
breakage?
a. Assess the patient's neck veins for distention.
b. Palpate the patient's arm.
c. Check the catheter for pinholes and tears.
d. Palpate the area around the insertion site.
7. The nurse is concerned that a patient's central venous access device (CVAD) may have become
dislodged. How might the nurse assess for this complication?
8. When caring for a patient who has a CVAD, which sign may indicate infection at the insertion site?
a. Occlusion alarm sounds on infusion pump.
b. Patient's oral temperature gradually increases.
c. Patient's neck veins become distended.
d. The nurse cannot achieve blood return.
9. Which instruction might the nurse give to nursing assistive personnel (NAP) regarding the care of a
patient with a CVAD?
a. "Assess the site frequently for signs of inflammation."
b. "Be sure to change the transparent dressing on the site once every 7 days."
c. "Let me know immediately if the patient's dressing becomes damp."
d. "Make sure the patient knows to notify me if the site is painful or swollen."
10. While palpating the skin around a patient’s CVAD insertion site, the nurse elicits a crackling
sound. What might this finding indicate?
a. Catheter occlusion
b. Infection
c. Skin erosion
d. Subcutaneous emphysema
C. LESSON WRAP-UP
AL Strategy: Minute Paper
1. Please prepare a question or write a question in an index cards or half-sheets of paper to write
feedback to the following questions:
a. What was the most useful or the most meaningful thing you have learned this session?
b. What question(s) do you have as we end this session?